PanGenomic Health (XCNQ:NARA) Cash-to-Debt : 0.02 (As of Sep. 2023)

View and export this data going back to 2022. Start your Free Trial

What is PanGenomic Health Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. PanGenomic Health's cash to debt ratio for the quarter that ended in Sep. 2023 was 0.02.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, PanGenomic Health couldn't pay off its debt using the cash in hand for the quarter that ended in Sep. 2023.

The historical rank and industry rank for PanGenomic Health's Cash-to-Debt or its related term are showing as below:

XCNQ:NARA' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.02 Med: 5000.44 Max: No Debt
Current: 0.02

During the past 2 years, PanGenomic Health's highest Cash to Debt Ratio was No Debt. The lowest was 0.02. And the median was 5000.44.

XCNQ:NARA's Cash-to-Debt is ranked worse than
92.48% of 665 companies
in the Healthcare Providers & Services industry
Industry Median: 0.71 vs XCNQ:NARA: 0.02

PanGenomic Health Cash-to-Debt Historical Data

The historical data trend for PanGenomic Health's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

PanGenomic Health Cash-to-Debt Chart

PanGenomic Health Annual Data

Trend

Dec21

Dec22

Cash-to-Debt

No Debt

0.87

PanGenomic Health Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Cash-to-Debt	Get a 7-Day Free Trial					No Debt	0.87	0.11	-	0.02

Competitive Comparison of PanGenomic Health's Cash-to-Debt

For the Health Information Services subindustry, PanGenomic Health's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PanGenomic Health's Cash-to-Debt Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, PanGenomic Health's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where PanGenomic Health's Cash-to-Debt falls into.

PanGenomic Health Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

PanGenomic Health's Cash to Debt Ratio for the fiscal year that ended in Dec. 2022 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	0.089	/	(0.102	+	0)
	=	0.87

PanGenomic Health's Cash to Debt Ratio for the quarter that ended in Sep. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	0.013	/	(0.627	+	0)
	=	0.02

PanGenomic Health (XCNQ:NARA) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

PanGenomic Health Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of PanGenomic Health's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

PanGenomic Health (XCNQ:NARA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » PanGenomic Health Inc (XCNQ:NARA) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

NARA:UK LL30:Germany

Address

3800 Wesbrook Mall, Suite 102, Vancouver, BC, CAN, V6S 2L9

Website

https://www.pangenomic.com

PanGenomic Health Inc is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments to support mental health. The company's mobile app, the Nara App, provides consumers with a knowledge base tailored to an individual's user profile, developed by tracking a user's treatment regimen and their specific genomic, proteomics, and microbiome data. The Company's mission is to promote and improve the health and wellness of people and society by providing a technology platform that identifies plant-based solutions tailored to the health profile of each individual.

Executives

Kaidong Zhang

Senior Officer

PanGenomic Health (XCNQ:NARA) Headlines

No Headlines